Report Overview
In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements
The global OTC and DTC Infectious Disease Diagnostic market size was estimated at USD 4870 million in 2023 and is projected to reach USD 8878.27 million by 2032, exhibiting a CAGR of 6.90% during the forecast period.
North America OTC and DTC Infectious Disease Diagnostic market size was estimated at USD 1423.52 million in 2023, at a CAGR of 5.91% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global OTC and DTC Infectious Disease Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global OTC and DTC Infectious Disease Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the OTC and DTC Infectious Disease Diagnostic market in any manner.
Global OTC and DTC Infectious Disease Diagnostic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Bio-Rad Laboratories Inc
BD
Bosch Healthcare Solutions GmbH
Danaher
ThermoFisher Scientific
Siemens AG
Roche Holding AG
Hologic
Inc.
Qiagen
Cardinal Health
Quest Diagnostics Incorporated
Ador Diagnostics
Akonni Biosystems
Inc.
Alveo Technologies
Binx Health Inc.
bioMérieux
Inc.
Curetis
Sysmex Europe GmbH
Diasorin S.p.A
Market Segmentation (by Type)
PCR
Immunodiagnostics
Clinical Microbiology
INAAT
DNA Sequencing and NGS
DNA Microarrays
Others
Market Segmentation (by Application)
Diagnostic Laboratories
Hospitals and Clinics
Academic Research Institutes
Others
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the OTC and DTC Infectious Disease Diagnostic Market
• Overview of the regional outlook of the OTC and DTC Infectious Disease Diagnostic Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the OTC and DTC Infectious Disease Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of OTC and DTC Infectious Disease Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of OTC and DTC Infectious Disease Diagnostic
1.2 Key Market Segments
1.2.1 OTC and DTC Infectious Disease Diagnostic Segment by Type
1.2.2 OTC and DTC Infectious Disease Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OTC and DTC Infectious Disease Diagnostic Market Overview
2.1 Global Market Overview
2.1.1 Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global OTC and DTC Infectious Disease Diagnostic Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OTC and DTC Infectious Disease Diagnostic Market Competitive Landscape
3.1 Global OTC and DTC Infectious Disease Diagnostic Sales by Manufacturers (2019-2025)
3.2 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Manufacturers (2019-2025)
3.3 OTC and DTC Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global OTC and DTC Infectious Disease Diagnostic Average Price by Manufacturers (2019-2025)
3.5 Manufacturers OTC and DTC Infectious Disease Diagnostic Sales Sites, Area Served, Product Type
3.6 OTC and DTC Infectious Disease Diagnostic Market Competitive Situation and Trends
3.6.1 OTC and DTC Infectious Disease Diagnostic Market Concentration Rate
3.6.2 Global 5 and 10 Largest OTC and DTC Infectious Disease Diagnostic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OTC and DTC Infectious Disease Diagnostic Industry Chain Analysis
4.1 OTC and DTC Infectious Disease Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of OTC and DTC Infectious Disease Diagnostic Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OTC and DTC Infectious Disease Diagnostic Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Type (2019-2025)
6.3 Global OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Type (2019-2025)
6.4 Global OTC and DTC Infectious Disease Diagnostic Price by Type (2019-2025)
7 OTC and DTC Infectious Disease Diagnostic Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global OTC and DTC Infectious Disease Diagnostic Market Sales by Application (2019-2025)
7.3 Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) by Application (2019-2025)
7.4 Global OTC and DTC Infectious Disease Diagnostic Sales Growth Rate by Application (2019-2025)
8 OTC and DTC Infectious Disease Diagnostic Market Consumption by Region
8.1 Global OTC and DTC Infectious Disease Diagnostic Sales by Region
8.1.1 Global OTC and DTC Infectious Disease Diagnostic Sales by Region
8.1.2 Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region
8.2 North America
8.2.1 North America OTC and DTC Infectious Disease Diagnostic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe OTC and DTC Infectious Disease Diagnostic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America OTC and DTC Infectious Disease Diagnostic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 OTC and DTC Infectious Disease Diagnostic Market Production by Region
9.1 Global Production of OTC and DTC Infectious Disease Diagnostic by Region (2019-2025)
9.2 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2019-2025)
9.3 Global OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America OTC and DTC Infectious Disease Diagnostic Production
9.4.1 North America OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2019-2025)
9.4.2 North America OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe OTC and DTC Infectious Disease Diagnostic Production
9.5.1 Europe OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2019-2025)
9.5.2 Europe OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan OTC and DTC Infectious Disease Diagnostic Production (2019-2025)
9.6.1 Japan OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2019-2025)
9.6.2 Japan OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China OTC and DTC Infectious Disease Diagnostic Production (2019-2025)
9.7.1 China OTC and DTC Infectious Disease Diagnostic Production Growth Rate (2019-2025)
9.7.2 China OTC and DTC Infectious Disease Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Abbott
10.1.1 Abbott OTC and DTC Infectious Disease Diagnostic Basic Information
10.1.2 Abbott OTC and DTC Infectious Disease Diagnostic Product Overview
10.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott OTC and DTC Infectious Disease Diagnostic SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Bio-Rad Laboratories Inc
10.2.1 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Basic Information
10.2.2 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Overview
10.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.2.4 Bio-Rad Laboratories Inc Business Overview
10.2.5 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic SWOT Analysis
10.2.6 Bio-Rad Laboratories Inc Recent Developments
10.3 BD
10.3.1 BD OTC and DTC Infectious Disease Diagnostic Basic Information
10.3.2 BD OTC and DTC Infectious Disease Diagnostic Product Overview
10.3.3 BD OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.3.4 BD OTC and DTC Infectious Disease Diagnostic SWOT Analysis
10.3.5 BD Business Overview
10.3.6 BD Recent Developments
10.4 Bosch Healthcare Solutions GmbH
10.4.1 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Basic Information
10.4.2 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
10.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.4.4 Bosch Healthcare Solutions GmbH Business Overview
10.4.5 Bosch Healthcare Solutions GmbH Recent Developments
10.5 Danaher
10.5.1 Danaher OTC and DTC Infectious Disease Diagnostic Basic Information
10.5.2 Danaher OTC and DTC Infectious Disease Diagnostic Product Overview
10.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.5.4 Danaher Business Overview
10.5.5 Danaher Recent Developments
10.6 ThermoFisher Scientific
10.6.1 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Basic Information
10.6.2 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Overview
10.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.6.4 ThermoFisher Scientific Business Overview
10.6.5 ThermoFisher Scientific Recent Developments
10.7 Siemens AG
10.7.1 Siemens AG OTC and DTC Infectious Disease Diagnostic Basic Information
10.7.2 Siemens AG OTC and DTC Infectious Disease Diagnostic Product Overview
10.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.7.4 Siemens AG Business Overview
10.7.5 Siemens AG Recent Developments
10.8 Roche Holding AG
10.8.1 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Basic Information
10.8.2 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Overview
10.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.8.4 Roche Holding AG Business Overview
10.8.5 Roche Holding AG Recent Developments
10.9 Hologic
10.9.1 Hologic OTC and DTC Infectious Disease Diagnostic Basic Information
10.9.2 Hologic OTC and DTC Infectious Disease Diagnostic Product Overview
10.9.3 Hologic OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.9.4 Hologic Business Overview
10.9.5 Hologic Recent Developments
10.10 Inc.
10.10.1 Inc. OTC and DTC Infectious Disease Diagnostic Basic Information
10.10.2 Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.10.3 Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.10.4 Inc. Business Overview
10.10.5 Inc. Recent Developments
10.11 Qiagen
10.11.1 Qiagen OTC and DTC Infectious Disease Diagnostic Basic Information
10.11.2 Qiagen OTC and DTC Infectious Disease Diagnostic Product Overview
10.11.3 Qiagen OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.11.4 Qiagen Business Overview
10.11.5 Qiagen Recent Developments
10.12 Cardinal Health
10.12.1 Cardinal Health OTC and DTC Infectious Disease Diagnostic Basic Information
10.12.2 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Overview
10.12.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.12.4 Cardinal Health Business Overview
10.12.5 Cardinal Health Recent Developments
10.13 Quest Diagnostics Incorporated
10.13.1 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Basic Information
10.13.2 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Overview
10.13.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.13.4 Quest Diagnostics Incorporated Business Overview
10.13.5 Quest Diagnostics Incorporated Recent Developments
10.14 Ador Diagnostics
10.14.1 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Basic Information
10.14.2 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Overview
10.14.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.14.4 Ador Diagnostics Business Overview
10.14.5 Ador Diagnostics Recent Developments
10.15 Akonni Biosystems
10.15.1 Akonni Biosystems OTC and DTC Infectious Disease Diagnostic Basic Information
10.15.2 Akonni Biosystems OTC and DTC Infectious Disease Diagnostic Product Overview
10.15.3 Akonni Biosystems OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.15.4 Akonni Biosystems Business Overview
10.15.5 Akonni Biosystems Recent Developments
10.16 Inc.
10.16.1 Inc. OTC and DTC Infectious Disease Diagnostic Basic Information
10.16.2 Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.16.3 Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.16.4 Inc. Business Overview
10.16.5 Inc. Recent Developments
10.17 Alveo Technologies
10.17.1 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Basic Information
10.17.2 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Overview
10.17.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.17.4 Alveo Technologies Business Overview
10.17.5 Alveo Technologies Recent Developments
10.18 Binx Health Inc.
10.18.1 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Basic Information
10.18.2 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.18.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.18.4 Binx Health Inc. Business Overview
10.18.5 Binx Health Inc. Recent Developments
10.19 bioMérieux
10.19.1 bioMérieux OTC and DTC Infectious Disease Diagnostic Basic Information
10.19.2 bioMérieux OTC and DTC Infectious Disease Diagnostic Product Overview
10.19.3 bioMérieux OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.19.4 bioMérieux Business Overview
10.19.5 bioMérieux Recent Developments
10.20 Inc.
10.20.1 Inc. OTC and DTC Infectious Disease Diagnostic Basic Information
10.20.2 Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
10.20.3 Inc. OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.20.4 Inc. Business Overview
10.20.5 Inc. Recent Developments
10.21 Curetis
10.21.1 Curetis OTC and DTC Infectious Disease Diagnostic Basic Information
10.21.2 Curetis OTC and DTC Infectious Disease Diagnostic Product Overview
10.21.3 Curetis OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.21.4 Curetis Business Overview
10.21.5 Curetis Recent Developments
10.22 Sysmex Europe GmbH
10.22.1 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Basic Information
10.22.2 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
10.22.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.22.4 Sysmex Europe GmbH Business Overview
10.22.5 Sysmex Europe GmbH Recent Developments
10.23 Diasorin S.p.A
10.23.1 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Basic Information
10.23.2 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Overview
10.23.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Market Performance
10.23.4 Diasorin S.p.A Business Overview
10.23.5 Diasorin S.p.A Recent Developments
11 OTC and DTC Infectious Disease Diagnostic Market Forecast by Region
11.1 Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast
11.2 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Region
11.2.4 South America OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of OTC and DTC Infectious Disease Diagnostic by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of OTC and DTC Infectious Disease Diagnostic by Type (2025-2032)
12.1.2 Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of OTC and DTC Infectious Disease Diagnostic by Type (2025-2032)
12.2 Global OTC and DTC Infectious Disease Diagnostic Market Forecast by Application (2025-2032)
12.2.1 Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. OTC and DTC Infectious Disease Diagnostic Market Size Comparison by Region (M USD)
Table 5. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Manufacturers (2019-2025)
Table 7. Global OTC and DTC Infectious Disease Diagnostic Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global OTC and DTC Infectious Disease Diagnostic Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC and DTC Infectious Disease Diagnostic as of 2022)
Table 10. Global Market OTC and DTC Infectious Disease Diagnostic Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers OTC and DTC Infectious Disease Diagnostic Sales Sites and Area Served
Table 12. Manufacturers OTC and DTC Infectious Disease Diagnostic Product Type
Table 13. Global OTC and DTC Infectious Disease Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of OTC and DTC Infectious Disease Diagnostic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. OTC and DTC Infectious Disease Diagnostic Market Challenges
Table 22. Global OTC and DTC Infectious Disease Diagnostic Sales by Type (K Units)
Table 23. Global OTC and DTC Infectious Disease Diagnostic Market Size by Type (M USD)
Table 24. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) by Type (2019-2025)
Table 25. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Type (2019-2025)
Table 26. Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) by Type (2019-2025)
Table 27. Global OTC and DTC Infectious Disease Diagnostic Market Size Share by Type (2019-2025)
Table 28. Global OTC and DTC Infectious Disease Diagnostic Price (USD/Unit) by Type (2019-2025)
Table 29. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) by Application
Table 30. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application
Table 31. Global OTC and DTC Infectious Disease Diagnostic Sales by Application (2019-2025) & (K Units)
Table 32. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Application (2019-2025)
Table 33. Global OTC and DTC Infectious Disease Diagnostic Sales by Application (2019-2025) & (M USD)
Table 34. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application (2019-2025)
Table 35. Global OTC and DTC Infectious Disease Diagnostic Sales Growth Rate by Application (2019-2025)
Table 36. Global OTC and DTC Infectious Disease Diagnostic Sales by Region (2019-2025) & (K Units)
Table 37. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region (2019-2025)
Table 38. North America OTC and DTC Infectious Disease Diagnostic Sales by Country (2019-2025) & (K Units)
Table 39. Europe OTC and DTC Infectious Disease Diagnostic Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales by Region (2019-2025) & (K Units)
Table 41. South America OTC and DTC Infectious Disease Diagnostic Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales by Region (2019-2025) & (K Units)
Table 43. Global OTC and DTC Infectious Disease Diagnostic Production (K Units) by Region (2019-2025)
Table 44. Global OTC and DTC Infectious Disease Diagnostic Revenue (US$ Million) by Region (2019-2025)
Table 45. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Region (2019-2025)
Table 46. Global OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China OTC and DTC Infectious Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Abbott OTC and DTC Infectious Disease Diagnostic Basic Information
Table 52. Abbott OTC and DTC Infectious Disease Diagnostic Product Overview
Table 53. Abbott OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Abbott Business Overview
Table 55. Abbott OTC and DTC Infectious Disease Diagnostic SWOT Analysis
Table 56. Abbott Recent Developments
Table 57. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Basic Information
Table 58. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Overview
Table 59. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Bio-Rad Laboratories Inc Business Overview
Table 61. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic SWOT Analysis
Table 62. Bio-Rad Laboratories Inc Recent Developments
Table 63. BD OTC and DTC Infectious Disease Diagnostic Basic Information
Table 64. BD OTC and DTC Infectious Disease Diagnostic Product Overview
Table 65. BD OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. BD OTC and DTC Infectious Disease Diagnostic SWOT Analysis
Table 67. BD Business Overview
Table 68. BD Recent Developments
Table 69. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Basic Information
Table 70. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
Table 71. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Bosch Healthcare Solutions GmbH Business Overview
Table 73. Bosch Healthcare Solutions GmbH Recent Developments
Table 74. Danaher OTC and DTC Infectious Disease Diagnostic Basic Information
Table 75. Danaher OTC and DTC Infectious Disease Diagnostic Product Overview
Table 76. Danaher OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Danaher Business Overview
Table 78. Danaher Recent Developments
Table 79. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Basic Information
Table 80. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Overview
Table 81. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. ThermoFisher Scientific Business Overview
Table 83. ThermoFisher Scientific Recent Developments
Table 84. Siemens AG OTC and DTC Infectious Disease Diagnostic Basic Information
Table 85. Siemens AG OTC and DTC Infectious Disease Diagnostic Product Overview
Table 86. Siemens AG OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Siemens AG Business Overview
Table 88. Siemens AG Recent Developments
Table 89. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Basic Information
Table 90. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Overview
Table 91. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Roche Holding AG Business Overview
Table 93. Roche Holding AG Recent Developments
Table 94. Hologic OTC and DTC Infectious Disease Diagnostic Basic Information
Table 95. Hologic OTC and DTC Infectious Disease Diagnostic Product Overview
Table 96. Hologic OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Hologic Business Overview
Table 98. Hologic Recent Developments
Table 99. Inc. OTC and DTC Infectious Disease Diagnostic Basic Information
Table 100. Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 101. Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Inc. Business Overview
Table 103. Inc. Recent Developments
Table 104. Qiagen OTC and DTC Infectious Disease Diagnostic Basic Information
Table 105. Qiagen OTC and DTC Infectious Disease Diagnostic Product Overview
Table 106. Qiagen OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Qiagen Business Overview
Table 108. Qiagen Recent Developments
Table 109. Cardinal Health OTC and DTC Infectious Disease Diagnostic Basic Information
Table 110. Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Overview
Table 111. Cardinal Health OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Cardinal Health Business Overview
Table 113. Cardinal Health Recent Developments
Table 114. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Basic Information
Table 115. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Overview
Table 116. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Quest Diagnostics Incorporated Business Overview
Table 118. Quest Diagnostics Incorporated Recent Developments
Table 119. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Basic Information
Table 120. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Overview
Table 121. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Ador Diagnostics Business Overview
Table 123. Ador Diagnostics Recent Developments
Table 124. Akonni Biosystems OTC and DTC Infectious Disease Diagnostic Basic Information
Table 125. Akonni Biosystems OTC and DTC Infectious Disease Diagnostic Product Overview
Table 126. Akonni Biosystems OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Akonni Biosystems Business Overview
Table 128. Akonni Biosystems Recent Developments
Table 129. Inc. OTC and DTC Infectious Disease Diagnostic Basic Information
Table 130. Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 131. Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. Inc. Business Overview
Table 133. Inc. Recent Developments
Table 134. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Basic Information
Table 135. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Overview
Table 136. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 137. Alveo Technologies Business Overview
Table 138. Alveo Technologies Recent Developments
Table 139. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Basic Information
Table 140. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 141. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 142. Binx Health Inc. Business Overview
Table 143. Binx Health Inc. Recent Developments
Table 144. bioMérieux OTC and DTC Infectious Disease Diagnostic Basic Information
Table 145. bioMérieux OTC and DTC Infectious Disease Diagnostic Product Overview
Table 146. bioMérieux OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 147. bioMérieux Business Overview
Table 148. bioMérieux Recent Developments
Table 149. Inc. OTC and DTC Infectious Disease Diagnostic Basic Information
Table 150. Inc. OTC and DTC Infectious Disease Diagnostic Product Overview
Table 151. Inc. OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 152. Inc. Business Overview
Table 153. Inc. Recent Developments
Table 154. Curetis OTC and DTC Infectious Disease Diagnostic Basic Information
Table 155. Curetis OTC and DTC Infectious Disease Diagnostic Product Overview
Table 156. Curetis OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 157. Curetis Business Overview
Table 158. Curetis Recent Developments
Table 159. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Basic Information
Table 160. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Overview
Table 161. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 162. Sysmex Europe GmbH Business Overview
Table 163. Sysmex Europe GmbH Recent Developments
Table 164. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Basic Information
Table 165. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Overview
Table 166. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 167. Diasorin S.p.A Business Overview
Table 168. Diasorin S.p.A Recent Developments
Table 169. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Region (2025-2032) & (K Units)
Table 170. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Region (2025-2032) & (M USD)
Table 171. North America OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 172. North America OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 173. Europe OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 174. Europe OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 175. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales Forecast by Region (2025-2032) & (K Units)
Table 176. Asia Pacific OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Region (2025-2032) & (M USD)
Table 177. South America OTC and DTC Infectious Disease Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 178. South America OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 179. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Consumption Forecast by Country (2025-2032) & (Units)
Table 180. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 181. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Type (2025-2032) & (K Units)
Table 182. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Type (2025-2032) & (M USD)
Table 183. Global OTC and DTC Infectious Disease Diagnostic Price Forecast by Type (2025-2032) & (USD/Unit)
Table 184. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) Forecast by Application (2025-2032)
Table 185. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of OTC and DTC Infectious Disease Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD), 2019-2032
Figure 5. Global OTC and DTC Infectious Disease Diagnostic Market Size (M USD) (2019-2032)
Figure 6. Global OTC and DTC Infectious Disease Diagnostic Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. OTC and DTC Infectious Disease Diagnostic Market Size by Country (M USD)
Figure 11. OTC and DTC Infectious Disease Diagnostic Sales Share by Manufacturers in 2023
Figure 12. Global OTC and DTC Infectious Disease Diagnostic Revenue Share by Manufacturers in 2023
Figure 13. OTC and DTC Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market OTC and DTC Infectious Disease Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by OTC and DTC Infectious Disease Diagnostic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global OTC and DTC Infectious Disease Diagnostic Market Share by Type
Figure 18. Sales Market Share of OTC and DTC Infectious Disease Diagnostic by Type (2019-2025)
Figure 19. Sales Market Share of OTC and DTC Infectious Disease Diagnostic by Type in 2023
Figure 20. Market Size Share of OTC and DTC Infectious Disease Diagnostic by Type (2019-2025)
Figure 21. Market Size Market Share of OTC and DTC Infectious Disease Diagnostic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application
Figure 24. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Application (2019-2025)
Figure 25. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Application in 2023
Figure 26. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application (2019-2025)
Figure 27. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application in 2023
Figure 28. Global OTC and DTC Infectious Disease Diagnostic Sales Growth Rate by Application (2019-2025)
Figure 29. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region (2019-2025)
Figure 30. North America OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America OTC and DTC Infectious Disease Diagnostic Sales Market Share by Country in 2023
Figure 32. U.S. OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada OTC and DTC Infectious Disease Diagnostic Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico OTC and DTC Infectious Disease Diagnostic Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe OTC and DTC Infectious Disease Diagnostic Sales Market Share by Country in 2023
Figure 37. Germany OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (K Units)
Figure 43. Asia Pacific OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region in 2023
Figure 44. China OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (K Units)
Figure 50. South America OTC and DTC Infectious Disease Diagnostic Sales Market Share by Country in 2023
Figure 51. Brazil OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa OTC and DTC Infectious Disease Diagnostic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa OTC and DTC Infectious Disease Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global OTC and DTC Infectious Disease Diagnostic Production Market Share by Region (2019-2025)
Figure 62. North America OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2019-2025)
Figure 65. China OTC and DTC Infectious Disease Diagnostic Production (K Units) Growth Rate (2019-2025)
Figure 66. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global OTC and DTC Infectious Disease Diagnostic Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global OTC and DTC Infectious Disease Diagnostic Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global OTC and DTC Infectious Disease Diagnostic Market Share Forecast by Type (2025-2032)
Figure 70. Global OTC and DTC Infectious Disease Diagnostic Sales Forecast by Application (2025-2032)
Figure 71. Global OTC and DTC Infectious Disease Diagnostic Market Share Forecast by Application (2025-2032)
